Free tool
FAERS Monitor: Potassium Chloride 30meq In Dextrose 5% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018371 or its brand name (Potassium Chloride 30meq In Dextrose 5% In Plastic Container, Dextrose, Potassium Chloride). Reports on generic versions are filed under their own applications.
Reports
15
Serious
8
53% of reports
Hospitalization
8
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- febrile neutropenia3
- renal ischaemia3
- anaemia2
- burkholderia test positive2
- covid-192
- endotracheal intubation2
- intercepted product selection error2
- product label confusion2
- product name confusion2
- pyrexia2
- respiratory rate decreased2
- white blood cell count decreased2
- abdominal mass1
- alopecia1
- blood count abnormal1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2014 | 1 |
| 2016 | 3 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,144 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| burkholderia test positive | 2 | 23010.0 | 6256.1 | 25,466 |
| renal ischaemiaSignal | 3 | 7740.5 | 2803.4 | 16,033 |
| product name confusion | 2 | 2577.8 | 708.5 | 2,892 |
| intercepted product selection error | 2 | 2159.4 | 593.6 | 2,423 |
| endotracheal intubation | 2 | 1001.1 | 275.4 | 1,123 |
| respiratory rate decreased | 2 | 893.4 | 245.8 | 1,002 |
| abdominal mass | 1 | 523.7 | 78.8 | 130 |
| product label confusion | 2 | 481.3 | 132.4 | 538 |
| blood count abnormal | 1 | 92.5 | 13.9 | 22 |
| febrile neutropeniaSignal | 3 | 63.4 | 23.0 | 128 |
| white blood cell count decreased | 2 | 25.9 | 7.1 | 26 |
| covid-19 | 2 | 16.0 | 4.4 | 15 |
| anaemia | 2 | 14.7 | 4.0 | 14 |
| pyrexia | 2 | 8.1 | 2.2 | 6 |
| alopecia | 1 | 7.1 | 1.1 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.